Dr. Ojo has extensive experience in the development and management of multicenter clinical trials. His overall research interests include hypertension, ESRD, and access to kidney transplantation and allograft survival in minority patients with ESRD. His current specific research interests include identifying the risk factors for accelerated decline in renal function in patients with chronic renal insufficiency and evaluating the incidence and risk factors for cardiovascular disease in this population. Dr. Ojo also participates in a multicenter, NIH-sponsored clinical trial, the African American Study of Kidney Disease (AASK).
Link to PubMed Citations
Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL, Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transplantation 2009 Feb;15(2):148-62.
Ojo AO, Christensen LL and Luan FL Living Donor Organ Transplantation. Editors: Rainer Gruessner and Enrico Benedetti. Retransplantation Chapter 16.10:282-287. Publisher: The McGraw-Hill Companies, Inc. 2008.
Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 2009 Jan;9(1):160-8. Epub 2008 Oct 24.
Fisher MA, Taylor GW, Shelton BJ, Jamerson KA, Rahman M, Ojo AO, Sehgal AR. Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Disease 2008 Jan;51(1):45-52.
Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Emond JC, Koffron AJ, Pruett TL, Olthoff KM; A2 ALL Study Group. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008 Aug;135(2):468-76. Epub 2008 Apr 22.
J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF, Ojo AO; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Liver Transpl. 2008 Sep;14(9):1273-80.
Luan FL, Zhang H, Schaubel DE, Miles CD, Cibrik D, Norman S, Ojo AO. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant, 2008 Sep;8(9):1871-7.
Fisher MA, Taylor GW, Shelton BJ, Jmaerson KA, Rahman M, Ojo AO, Sehgal AR. Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis 51(1):45-52, 2008.
Ojo AO. Renal disease in recipients of non-renal solid organ transplantation. Semin Nephrol 27(4):498-507, 2007.
LuanFL, Miles CD, Cibrik DM, Ojo AO. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 84(4):541-544, 2007.
Lee Ck, Christensen LL, Magee JC, Ojo AO, Harmon WE, Bridges ND. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study. J Heart Lung Transplant 26(5):458-65, 2007.
Miles C, Schaubel DE, Jia X, Ojo AO, Port FK, Rao PS. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant 7(5):1140-1147, 2007.
Luan FL. Chopra P. Park J. Norman S. Cibrik D. Ojo A. Efficacy of valganciclovir in the treatment of cytomegalovirus disease in kidney and pancreas transplant recipients. Transplant Proc 38(10):3673-3675, 2006.
Ojo AO. Cardiovascular complication after renal transplantation and their prevention. Transplantation 82(5):603-611, 2006.
Ojo AO. Effect of pre-implantation histologic assessment on long-term outcomes of kidneys from older donors. Natl Clin Pract Nephrol 2(9):482-483, 2006.
Ojo AO, Luan FL , Sung RS, Merion RM. The use of expanded criteria donor organs for transplantation. Transplantation reviews 20(1):41-48, 2006.
Ojo AO. Renal failure in non-renal organ transplantation. In: Contemporary Nephrology, 4th Ed.
Epidemiology of Chronic Kidney Disease. In: Primer on Kidney Disease, Arthur Greenberg, Ed. Academic Press, 2005.
Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, Ojo AO, Port FK. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294(21):2726-2733, 2005.
Ojo AO. Expanded criteria donors: process and outcomes. Semin Dial 18(6):463-46, 2005.
Contreras G, Greene T, Agodoa LY, Cheek D, Junco G, Dowie D, Lash J, Lipkowitz M, Miller ER 3rd, Ojo AO, Sika M, Wilkening B, Toto RD; African American Study of Kidney Disease and Hypertension Study Group Investigators. Blood pressure control, drug therapy, and kidney disease. Hypertension. 46(1):44-50, 2005.
Ojo AO, Pietroski RE, O’Connor K, McGowan JJ, Dickinson DM. Quantifying organ donation rates by donation service area. Am J Transplant 4(pt2):958-966, 2005.
Phillips RA, Faulkner M, Gassman J, Jaen L, Kusek JW, Norris K, Ojo AO. Recruitment of African Americans with chronic renal insufficiency into a multicenter clinical trial: the african american study of kidney disease and hypertension. J Clin Hypertens 6:430-436, 2004.
Ojo AO, Heinrichs D, Emond JC, McGowan JJ, Guidinger MK, Delmonico FL, Metzger RA. SRTR Report on the State of Transplantation : Organ Donation in the United States . Am J Transplant 4(Suppl 9): 27-37, 2004.
Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, Leichtman AB, Held PJ, Port FK. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 4:87-93, 2004.